These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4999653)

  • 21. Analogues of N-benzyloxydihydrotriazines: in vitro antimalarial activity against Plasmodium falciparum.
    Childs GE; Lambros C
    Ann Trop Med Parasitol; 1986 Apr; 80(2):177-81. PubMed ID: 3530157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
    Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
    Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of sporontocidal compounds using Plasmodium falciparum gametocytes produced in vitro.
    Teklehaimanot A; Nguyen-Dinh P; Collins WE; Barber AM; Campbell CC
    Am J Trop Med Hyg; 1985 May; 34(3):429-34. PubMed ID: 3890574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood schizontocidal activity of antibiotics against Plasmodium berghei sensitive as well as resistant to chloroquine, pyrimethamine and primaquine.
    Puri SK; Dutta GP
    Indian J Med Res; 1981 Jan; 73 Suppl():29-35. PubMed ID: 7026431
    [No Abstract]   [Full Text] [Related]  

  • 25. [Presence of pyrimethamine and cycloguanil resistance genotype in West Africa? Evidence of a single mutation 59Arg in the dhfr gene of Plasmodium falciparum].
    Pinheiro L; Rosário VE
    Acta Med Port; 2003; 16(4):235-8. PubMed ID: 22226208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The lethal effect of certain antimalarial drugs on Tetrahymena pyriformis.
    Clancy CF
    Am J Trop Med Hyg; 1968 May; 17(3):359-63. PubMed ID: 5652696
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies concerning the mechanism of action of antimalarial drugs. Inhibition of the incorporation of adenosine-8-3H into nucleic acids of Plasmodium berghei.
    Van Dyke K; Szustkiewicz C; Lantz CH; Saxe LH
    Biochem Pharmacol; 1969 Jun; 18(6):1417-25. PubMed ID: 4895016
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
    Randrianarivelojosia M; Harisoa JL; Rabarijaona LP; Raharimalala LA; Ranaivo L; Pietra V; Duchemin JB; Rakotomanana F; Robert V; Mauclere P; Ariey F
    Parassitologia; 2002 Dec; 44(3-4):141-7. PubMed ID: 12701375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental studies of the potentiation of proguanil and pyrimethamine by dapsone using Plasmodium berghei in white mice.
    Black RH; Ray AP
    Ann Trop Med Parasitol; 1977 Jun; 71(2):131-9. PubMed ID: 326205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antimalarial drugs on human neutrophil chemotaxis in vitro.
    Kharazmi A; Valerius NH; Høiby N
    Acta Pathol Microbiol Immunol Scand C; 1983 Aug; 91(4):293-8. PubMed ID: 6637481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chloroquine and dihydroquinine. In vitro studies by their antimalarial effect upon Plasmodium knowlesi.
    Polet H; Barr CF
    J Pharmacol Exp Ther; 1968 Dec; 164(2):380-6. PubMed ID: 4972437
    [No Abstract]   [Full Text] [Related]  

  • 32. Plasmodium gallinaceum: avian screen for drugs with radical curative properties.
    Gwadz RW; Koontz LC; Miller LH; Davidson DE
    Exp Parasitol; 1983 Apr; 55(2):188-96. PubMed ID: 6832279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasmodium: resistance to antimalarial drugs.
    Peters W
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():103-6. PubMed ID: 2264669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methaemoglobin levels in soldiers receiving antimalarial drugs.
    Sietsma A; Naughton MA; Harley JD
    Med J Aust; 1971 Feb; 1(9):473-5. PubMed ID: 5552440
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug sensitivity of exo-erythrocytic stages in pyrimethamine-resistant Plasmodium berghei.
    Diggens SM; Gregory KG
    Trans R Soc Trop Med Hyg; 1970; 64(4):468-9. PubMed ID: 5485600
    [No Abstract]   [Full Text] [Related]  

  • 36. [Limits of the efficacy of chloroquine and sulfadoxine-pyrimethamine in Northern Abidjan (Cote d'Ivoire): Combined in vivo and in vitro studies].
    Djaman J; Abouanou S; Basco L; Koné M
    Sante; 2004; 14(4):205-9. PubMed ID: 15745869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Falciparum malaria resistant to chloroquine, quinine and Fansidar in a non-immune patient infected in Ghana.
    Nguyen C; Gregson D; Mouldey P; Keystone JS
    Trans R Soc Trop Med Hyg; 1989; 83(4):485-6. PubMed ID: 2694485
    [No Abstract]   [Full Text] [Related]  

  • 38. Activity of dihydrofolate reductase inhibitors on the hepatic stages of Plasmodium yoelii yoelii in vitro.
    Eriksson B; Courtier B; Bjŏrkman A; Miltgen F; Mazier D
    Trans R Soc Trop Med Hyg; 1991; 85(6):725-6. PubMed ID: 1801335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies on the chemoresistance of Plasmodium falciparum in Africa: current data].
    Nguyen-Dinh P
    Ann Soc Belg Med Trop; 1985; 65 Suppl 2():105-13. PubMed ID: 3907528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.